Last update 20 Mar 2025

Sulbactam sodium/Amoxicillin Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Picillibacta, ピシリバクタ, 威奇达
Target
β-lactamase
Action
inhibitors
Mechanism
β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors
Therapeutic Areas
Infectious Diseases
Active Indication
Bacterial Infections
Inactive Indication
Abdominal sepsisAbscess of oral tissueCellulitis+ [17]
Originator Organization
Pfizer Inc.Pfizer Inc.
Active Organization
Jiangxi Dongfeng Pharmaceutical Co. Ltd.Jiangxi Dongfeng Pharmaceutical Co. Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (01 Jan 2001),
Bacterial Infections
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC8H11NNaO5S
InChIKeySXKMQCSYTIDQTC-IBTYICNHSA-N
CAS Registry69388-84-7
View All Structures (2)

Related

1
Clinical Trials associated with Sulbactam sodium/Amoxicillin Sodium
CTR20130678
/ SuspendedPhase 2
注射用阿莫西林钠舒巴坦钠（4:1）治疗细菌性感染随机、单盲、阳性药对照的多中心临床试验
[Translation] A randomized, single-blind, positive-controlled, multicenter clinical trial of amoxicillin sodium and sulbactam sodium for injection (4:1) in the treatment of bacterial infections
100 Clinical Results associated with Sulbactam sodium/Amoxicillin Sodium
Login to view more data
100 Translational Medicine associated with Sulbactam sodium/Amoxicillin Sodium
Login to view more data
100 Patents (Medical) associated with Sulbactam sodium/Amoxicillin Sodium
Login to view more data
100 Deals associated with Sulbactam sodium/Amoxicillin Sodium
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bacterial Infections
China
Jiangxi Dongfeng Pharmaceutical Co. Ltd.Jiangxi Dongfeng Pharmaceutical Co. Ltd.
01 Jan 2001
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Abdominal sepsisPhase 3
China
-17 Oct 2013
Abscess of oral tissuePhase 3
China
-17 Oct 2013
CellulitisPhase 3
China
-17 Oct 2013
GonorrheaPhase 3
China
-17 Oct 2013
Gynecological infectionPhase 3
China
-17 Oct 2013
Intrauterine infectionPhase 3
China
-17 Oct 2013
LaryngitisPhase 3
China
-17 Oct 2013
Pelvic Inflammatory DiseasePhase 3
China
-17 Oct 2013
PleurisyPhase 3
China
-17 Oct 2013
TonsillitisPhase 3
China
-17 Oct 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free